iohexol has been researched along with Esophageal Neoplasms in 7 studies
Iohexol: An effective non-ionic, water-soluble contrast agent which is used in myelography, arthrography, nephroangiography, arteriography, and other radiographic procedures. Its low systemic toxicity is the combined result of low chemotoxicity and low osmolality.
iohexol : A benzenedicarboxamide compound having N-(2,3-dihydroxypropyl)carbamoyl groups at the 1- and 3-positions, iodo substituents at the 2-, 4- and 6-positions and an N-(2,3-dihydroxypropyl)acetamido group at the 5-position.
Esophageal Neoplasms: Tumors or cancer of the ESOPHAGUS.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Patients from one institution who had dysphagia caused by inoperable esophageal cancer were randomly assigned to receive treatment with a stent loaded with (125)I seeds (irradiation stent group) or a conventional covered stent (control group)." | 2.73 | Self-expandable esophageal stent loaded with 125I seeds: initial experience in patients with advanced esophageal cancer. ( Deng, G; Fang, W; Guo, JH; He, SC; Li, GZ; Teng, GJ; Zhu, GY, 2008) |
| "Eighty-seven patients with esophageal cancer underwent computed tomography (CT) using a third-generation dual-source system before surgery." | 1.56 | Visibility of bronchial arteries using virtual and advanced virtual monoenergetic imaging. ( Hashimoto, J; Imai, Y; Niwa, T; Nomura, T; Ozawa, S, 2020) |
| "Thirty-two patients with oesophageal squamous cell carcinomas underwent first-pass perfusion with 64-section MDCT at 50 mAs." | 1.38 | Quantitative assessment of first-pass perfusion using a low-dose method at multidetector CT in oesophageal squamous cell carcinoma: correlation with VEGF expression. ( Chen, HJ; Chen, TW; Dong, ZH; He, D; Li, Y; Tang, SS; Yang, ZG; Yao, J, 2012) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (28.57) | 29.6817 |
| 2010's | 4 (57.14) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Nomura, T | 1 |
| Niwa, T | 1 |
| Ozawa, S | 1 |
| Imai, Y | 1 |
| Hashimoto, J | 1 |
| Ulla, M | 1 |
| Cavadas, D | 1 |
| Muñoz, I | 1 |
| Beskow, A | 1 |
| Seehaus, A | 1 |
| García-Mónaco, R | 1 |
| Chen, TW | 3 |
| Yang, ZG | 3 |
| Wang, QL | 2 |
| Li, Y | 3 |
| Qian, LL | 2 |
| Chen, HJ | 2 |
| Dong, ZH | 2 |
| Yao, J | 2 |
| Tang, SS | 1 |
| He, D | 1 |
| Guo, JH | 1 |
| Teng, GJ | 1 |
| Zhu, GY | 1 |
| He, SC | 1 |
| Fang, W | 1 |
| Deng, G | 1 |
| Li, GZ | 1 |
| Jin, GY | 1 |
| Park, SH | 1 |
| Han, YM | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Phase IV Study of Self-Expandable Esophageal Stent Loaded With 125I Seeds: a Randomized Controlled Multiple Center Trial in Patients With Advanced Esophageal Cancer[NCT00826813] | 250 participants (Actual) | Interventional | 2009-01-31 | Active, not recruiting | |||
| Self-Expandable Esophageal Radiation Stent:a Multicentric Randomized Controlled Trial in Patients With Advanced Esophageal Cancer[NCT01054274] | Phase 3 | 180 participants (Anticipated) | Interventional | 2009-12-31 | Recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 trial available for iohexol and Esophageal Neoplasms
| Article | Year |
|---|---|
Self-expandable esophageal stent loaded with 125I seeds: initial experience in patients with advanced esophageal cancer.
Topics: Aged; Aged, 80 and over; Brachytherapy; Contrast Media; Deglutition Disorders; Esophageal Neoplasms; | 2008 |
Self-expandable esophageal stent loaded with 125I seeds: initial experience in patients with advanced esophageal cancer.
Topics: Aged; Aged, 80 and over; Brachytherapy; Contrast Media; Deglutition Disorders; Esophageal Neoplasms; | 2008 |
Self-expandable esophageal stent loaded with 125I seeds: initial experience in patients with advanced esophageal cancer.
Topics: Aged; Aged, 80 and over; Brachytherapy; Contrast Media; Deglutition Disorders; Esophageal Neoplasms; | 2008 |
Self-expandable esophageal stent loaded with 125I seeds: initial experience in patients with advanced esophageal cancer.
Topics: Aged; Aged, 80 and over; Brachytherapy; Contrast Media; Deglutition Disorders; Esophageal Neoplasms; | 2008 |
6 other studies available for iohexol and Esophageal Neoplasms
| Article | Year |
|---|---|
Visibility of bronchial arteries using virtual and advanced virtual monoenergetic imaging.
Topics: Adult; Aged; Aged, 80 and over; Bronchial Arteries; Computed Tomography Angiography; Contrast Media; | 2020 |
Esophageal cancer: pneumo-64-MDCT.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Catheterization; Contrast | 2010 |
Whole tumour quantitative measurement of first-pass perfusion of oesophageal squamous cell carcinoma using 64-row multidetector computed tomography: correlation with microvessel density.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Contrast Media; Esophageal Neoplasms; Female; Humans; Immunoe | 2011 |
Whole tumour first-pass perfusion using a low-dose method with 64-section multidetector row computed tomography in oesophageal squamous cell carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Contrast Media; Esophageal Neoplasms; Fema | 2011 |
Quantitative assessment of first-pass perfusion using a low-dose method at multidetector CT in oesophageal squamous cell carcinoma: correlation with VEGF expression.
Topics: Adult; Aged; Aged, 80 and over; Blood Volume; Carcinoma, Squamous Cell; Contrast Media; Esophageal N | 2012 |
Usefulness of MDCT evaluation of the intraluminal surface of esophageal masses using only effervescent powder without injection of hypotonic agent.
Topics: Adult; Aged; Aged, 80 and over; Analysis of Variance; Contrast Media; Diagnosis, Differential; Esoph | 2009 |